Dysregulated Urea-synthesis at Terminal Uremia
- Conditions
- Urea Cycle DisorderUremia
- Interventions
- Other: Aminoacid, alanine-infusion
- Registration Number
- NCT05076318
- Lead Sponsor
- University of Aarhus
- Brief Summary
This project will examine the dysregulation of the urea cycle in patients with terminal uremia using a validated method named "Functional Hepatic Nitrogen Clearance"
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 16
- Age > or equal to 18 years
- Chronic hemodialysis during 3 months
- Patients with functioning arteriovenous-fistula assigned to "Center-Hemodialysis" at "Nyresygdomme, AUH Skejby"
- Active infection
- Conditions with vomiting or diarrhea
- Diabetes
- Active disease being treated with chemotherapy, radiationtherapy, biologic- or similar treatments. Disease under observation can be included.
- Liver disease
- Vessels on the upper extremities not suited for cannulation
- Prednisolone treatment during the last 8 weeks
- Pregnancy
- BMI > or equal to 30 or < or equal to 18
- Physically or mentally condition that does not allow the project to be completed
- Language-difficulties that does not allow the project to be completed
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Alanine-infusion Aminoacid, alanine-infusion Alanine infusion taking place over a 3 hour period while monitorering metabolic changes in blood samples before and after dialysis
- Primary Outcome Measures
Name Time Method Urea synthesis rate during alanine infusion 4 hours. 1 hour of blood sample measuring of baseline urea-synthesis rate and 3 hours of urea-synthesis rate during alanine-infusion Change in the synthesis of urea during a 3 hour period of alanine-infusion in pre and post hemodialysis patients. We will use a validated method named functional hepatic nitrogen clearance (FHNC) to evaluate the synthesis of urea. FHNC is calculated using the linear relation between urea nitrogen synthesis rate and blood-amino acid which is measured every hour. An estimated group of 10 dialysis patients will be included and compared to a clinical healthy group. The healthy group has also received alanine infusion and blood samples of urea and amino-acids has likewise been measured for every hour of infusion.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital Aarhus
🇩🇰Aarhus N, Denmark